Comparative Responses to Propofol Anaesthesia alone and with α2-Adrenergic Medications in a Canine Model
Acta Veterinaria Scandinavica volume 37, pages 187–201 (1996)
Cardiovascular and pulmonary effects of pro-pofol, a relatively new nonbarbiturate intravenous anaesthetic, were assessed and com-pared in 22 male and female dogs. Dogs in group 1 did not receive any premedication prior to 6.6 mg/kg IV propofol, group 2 was premedicated with atropine (0.02 mg/kg IM) and the α2-agonist medetomidine (10 μg/kg IM), and group 3 received the same premedication agents as group 2, but the medetomidine effects were reversed by the α2-antagonist atipamezole (30 μg/kg IV) after 30 min of anaesthesia. Each dog in groups 2 and 3 received a propofol induction dose of 2.2 mg/kg IV The anaesthetic du-ration was shortest with propofol alone and prolonged with medetomidine as a premedication which was reversible with atipamezole. In group 1, the most prominent effects were a temporary drop in diastolic arterial blood pressure (26% and 24%) at 2 and 5 min post-propofol, respectively and a drop in respiratory frequency (41%) 2 min after pro-pofol induction. Similar respiratory depression was observed in groups 2 and 3 (20% and 48%, respectively) at the same time. Apnea was not observed. An increase in systemic arterial blood pressure was observed throughout the trial in groups 2 and 3 un-til dogs recovered or were reversed with atipamezole. Medetomidine significantly re-duces propofol dosage requirements. Safe and effective injectable anaesthesia was pro-duced by propofol in this group of dogs. The frequency of respiratory depression would suggest in clinical usage, the practitioner should be aware oxygen supplementation is the treatment of choice should apnea occur.
Altman DG: Practical statistics for medical research. 1st ed. Chapman and Hall, London 1991.
Bergström K: Cardiovascular and pulmonary effects of a new sedative/analgesic (medetomidine) as a preanaesthetic drug in the dog. Acta vet. scand. 1988, 29, 109–116.
Biebuyck JF, Phil D: Propofol a new intravenous an-aesthetic. Anesthesiology 1989, 71, 261–277.
Claeys MA, Gepts E, Camu F: Hemodynamic changes during anaesthesia induced and main-tained with propofol. Brit. J. Anaesth. 1983, 60, 3–9.
Coates DP, Monk CR, Prys-Roberts C, Turtle M: He-modynamic effects of infusion of the emulsion formulation of propofol during nitrous oxide an-aesthesia in humans. Anaesth Analg. 1987, 66, 64–70.
Cullen PM, Turtle M, Prys-Roberts C, Way WL, Dye J: Effect of propofol anaesthesia on baroreflex activity in humans. Anaesth. Analg. 1987, 66, 1115–1120.
Dunkle N, Moise NS, Scarlett-Kranz J, Short CE: Cardiac performance in cats after administration of xylazine or xylazine and glycopyrrolate: Echocardiographic evaluation. Amer. J. vet. Res. 1986 47, 2212–2216.
Dye D, Walkins J: Suspected anaphylactic reaction to cremophor EL. Brit. Med. J. 1980, 280, 1353.
Goodchild GS, Serrão JM: Cardiovascular effects of propofol in the anesthetized dog. Brit. J. Anaesth. 1989, 63, SI–92.
Grounds RM, TwigleyAJ, Carli F: The hemodynamic effects of thiopentone and propofol. Anaesthesia 1985, 40, 735.
Karlsson BR, Forsman M, Roald OK, Heier MS, Steen PA: Effect of dexmedetomidine, a selective and potent α2-agonist, in cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth. Analg. 1990, 71, 125–129.
Klement W, Arndt JO: Pain on injection of propofol: effects of concentration and diluent. Brit. J. An-aesth. 1991,(57, 281–284.
Langley MS, Heel RC: Propofol a review of its phar-macokinetic properties and use as an intravenous anaesthetic. Drugs 1988, 35, 334–372.
MacKenzie N, Grant IS: Propofol for intravenous se-dation. Anaesthesia 1987, 42, 3–6.
Major E, Verniquet AJW, Waddel TK, Savege TM, Hüffler DE, Aveling W: A study of three doses of ICI 35 868 for induction and maintenance of anaesthesia. Brit. J. Anaesth. 1981, 53, 267–272.
Miller RD: Anaesthesia. 1st ed. Churchill and Liv-ingstone, London 1990.
Nakamura K, Hatano Y, Hirakata H, Nishiwada M, Toda H, Mori K: Direct vasoconstrictor and vaso-dilator effects on propofol in isolated dog arter-ies. Brit. J. Anaesth. 1992, 68, 193–197.
Sawyer DC, Brown M, Striler EL, Durham RA, Lang-ham MA, Rech RH: Comparison of direct and in-direct blood pressure measurement in anaesthe-tized dogs. Lab. Anim. Sci 1991, 41, 134–138.
Sebel PS, Lowdon JD: Propofol: a new intravenous anaesthetic. Anesthesiology 1989, 71, 1260–1277.
Short CE: The effects of sedative α2-adrenoceptor agonists on cardiovascular and pulmonary func-tions and brain wave activity in horses and dogs. Veterinary Practice Publishing Company, Santa Barbara, California 1991.
Short CE: α2-agents in animals. Veterinary Practice Publishing Company, Santa Barbara, California 1992.
Short CE: Principles and Practice of Veterinary An-aesthesia. William and Wilkins, Baltimore, Maryland 1987.
Smith JA, Gaynor JA, Bednarski RM, Muir WW: Ad-verse effects of administration of propofol with various preanaesthetic regimens in dog. J. Amer, vet. med. Assoc 1993, 202, 1111–1115.
Sneyd RJ, Berry A: Effect of preinduction glycopyr-rolate on the hemodynamic response to anaesthe-sia with propofol. Anaesth. Analg. 1991, 72, 831–834.
StaufferJL.: Personal communication. 1995. Vähä-Vahe AT: The clinical effectiveness of atipam-ezole as a medetomidine agonist in the dog. J. Vet. Pharm. Therap. 1990, 13, 198–205.
Vainio O: Reversal of medetomidine-induced cardio-vascular and respiratory change with atipamezole in dogs. Vet. Ree. 1990, 727, 447–450.
Vainio O: Propofol infusion anaesthesia in dogs pre-medicated with medetomidine. J. vet. Anaesth. 1991, 18, 35–37.
Vainio O, Palmu L: Cardiovascular and respiratory ef-fects of medetomidine in dogs and influence of anti-cholinergic. Acta vet. scand. 1989, 30, 401–408.
Watkins SB, HallLW, Clark KW: Propofol as an intra-venous anaesthetic agent in dogs. Vet. Ree. 1987, 120, 326–329.
Weaver BMQ, Raptopoulos D: Induction of an-aesthesia in dogs and cats with propofol. Vet. Ree. 1990, 126, 617–620.
WhitesellR, Asiddao C, Gollman D, HablovskiJ: Re-lationship between arterial and peak expired car-bon dioxide pressure during anaesthesia and fac-tors influencing the difference. Anaesth. Analg. 1981, 00, 508–512.
Young LE, Brearley JC, Richards DLS, Bartram DH, Jones RS: Medetomidine as a premedicant in dogs and its reversal by atipamezole. J. Small Anim. Pract. 1990, 31, 554–559.
Zornow MH, Fleischer JE, Schellar MS, Nakakimura K, Drummond JC: Dexmedetomidine, an α2-ad-renergic agonist, decreases cerebral blood flow in the isoflurane-anaesthetized dog. Anesth. Analg. 1990, 70, 625–630.
About this article
Cite this article
Bufalari, A., Short, C.E., Giannoni, C. et al. Comparative Responses to Propofol Anaesthesia alone and with α2-Adrenergic Medications in a Canine Model. Acta Vet Scand 37, 187–201 (1996). https://doi.org/10.1186/BF03548111